These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34795215)

  • 21. Targeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and Treatment.
    Willis RE
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The landscape and therapeutic relevance of cancer-associated transcript fusions.
    Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
    Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer.
    Wang C; Zhang Z; Sun Y; Wang S; Wu M; Ou Q; Xu Y; Chen Z; Shao Y; Liu H; Hou P
    J Transl Med; 2022 Sep; 20(1):390. PubMed ID: 36059009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases.
    Vaishnavi A; Schubert L; Rix U; Marek LA; Le AT; Keysar SB; Glogowska MJ; Smith MA; Kako S; Sumi NJ; Davies KD; Ware KE; Varella-Garcia M; Haura EB; Jimeno A; Heasley LE; Aisner DL; Doebele RC
    Cancer Res; 2017 Jul; 77(13):3551-3563. PubMed ID: 28428274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer.
    Lee S; Hu Y; Loo SK; Tan Y; Bhargava R; Lewis MT; Wang XS
    Proc Natl Acad Sci U S A; 2020 May; 117(18):9912-9921. PubMed ID: 32321829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degrons in cancer.
    Mészáros B; Kumar M; Gibson TJ; Uyar B; Dosztányi Z
    Sci Signal; 2017 Mar; 10(470):. PubMed ID: 28292960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer.
    Thangapazham R; Saenz F; Katta S; Mohamed AA; Tan SH; Petrovics G; Srivastava S; Dobi A
    BMC Cancer; 2014 Jan; 14():16. PubMed ID: 24418414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human transcription factor and protein kinase gene fusions in human cancer.
    Salokas K; Weldatsadik RG; Varjosalo M
    Sci Rep; 2020 Aug; 10(1):14169. PubMed ID: 32843691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel partner gene, KIAA1217, fused to RET: Functional characterization and inhibitor sensitivity of two isoforms in lung adenocarcinoma.
    Lee MS; Kim RN; I H; Oh DY; Song JY; Noh KW; Kim YJ; Yang JW; Lira ME; Lee CH; Lee MK; Kim YD; Mao M; Han J; Kim J; Choi YL
    Oncotarget; 2016 Jun; 7(24):36101-36114. PubMed ID: 27150058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
    Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer.
    Gow CH; Liu YN; Li HY; Hsieh MS; Chang SH; Luo SC; Tsai TH; Chen PL; Tsai MF; Shih JY
    Neoplasia; 2018 Aug; 20(8):838-847. PubMed ID: 30015159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of the Notch effector RBPJ promotes tumorigenesis.
    Kulic I; Robertson G; Chang L; Baker JH; Lockwood WW; Mok W; Fuller M; Fournier M; Wong N; Chou V; Robinson MD; Chun HJ; Gilks B; Kempkes B; Thomson TA; Hirst M; Minchinton AI; Lam WL; Jones S; Marra M; Karsan A
    J Exp Med; 2015 Jan; 212(1):37-52. PubMed ID: 25512468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.
    Sekine S; Kiyono T; Ryo E; Ogawa R; Wakai S; Ichikawa H; Suzuki K; Arai S; Tsuta K; Ishida M; Sasajima Y; Goshima N; Yamazaki N; Mori T
    J Clin Invest; 2019 May; 129(9):3827-3832. PubMed ID: 31145701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UHRF2 promotes intestinal tumorigenesis through stabilization of TCF4 mediated Wnt/β-catenin signaling.
    Li L; Duan Q; Zeng Z; Zhao J; Lu J; Sun J; Zhang J; Siwko S; Wong J; Shi T; Zhang X; Liu M; Chen J; Li D
    Int J Cancer; 2020 Oct; 147(8):2239-2252. PubMed ID: 32372448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of an MLL1 fusion and its role in chromosomal instability.
    Parameswaran S; Vizeacoumar FS; Kalyanasundaram Bhanumathy K; Qin F; Islam MF; Toosi BM; Cunningham CE; Mousseau DD; Uppalapati MC; Stirling PC; Wu Y; Bonham K; Freywald A; Li H; Vizeacoumar FJ
    Mol Oncol; 2019 Feb; 13(2):422-440. PubMed ID: 30548174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of RET fusions in a Chinese multicancer retrospective analysis by next-generation sequencing.
    Shi M; Wang W; Zhang J; Li B; Lv D; Wang D; Wang S; Cheng D; Ma T
    Cancer Sci; 2022 Jan; 113(1):308-318. PubMed ID: 34710947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PCGF2 negatively regulates arsenic trioxide-induced PML-RARA protein degradation via UBE2I inhibition in NB4 cells.
    Jo S; Lee YL; Kim S; Lee H; Chung H
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1499-509. PubMed ID: 27030546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-degron and C-degron pathways of protein degradation.
    Varshavsky A
    Proc Natl Acad Sci U S A; 2019 Jan; 116(2):358-366. PubMed ID: 30622213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The C-degron pathway eliminates mislocalized proteins and products of deubiquitinating enzymes.
    Yeh CW; Huang WC; Hsu PH; Yeh KH; Wang LC; Hsu PW; Lin HC; Chen YN; Chen SC; Yeang CH; Yen HS
    EMBO J; 2021 Apr; 40(7):e105846. PubMed ID: 33469951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenic long intervening noncoding RNA Linc00284 promotes c-Met expression by sponging miR-27a in colorectal cancer.
    You J; Li J; Ke C; Xiao Y; Lu C; Huang F; Mi Y; Xia R; Li Q
    Oncogene; 2021 Jun; 40(24):4151-4166. PubMed ID: 34050266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.